Cytokinetics (CYTK)
(Delayed Data from NSDQ)
$48.66 USD
-0.63 (-1.28%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $48.66 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Cytokinetics, Incorporated's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CYTK 48.66 -0.63(-1.28%)
Will CYTK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CYTK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CYTK
Cytokinetics Gains on Positive Late-Stage Cardiomyopathy Study Results
Company News for Sep 3, 2025
CYTK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Camzyos Strengthen BMY's Cardiovascular Portfolio?
Cytokinetics (CYTK) Reports Q2 Loss, Tops Revenue Estimates
Techne (TECH) Beats Q4 Earnings and Revenue Estimates
Other News for CYTK
CYTK forms 1,2,3 Pullback Bullish on September 18
Cytokinetics Faces Lawsuit Over Misleading Investors
CYTK forms MACD Bearish Signal Line Cross on September 18
Cytokinetics (CYTK) Rises on Convertible Note Offering Plan
Morning Movers: Workday surges after Elliot stake, stock buyback program